| Literature DB >> 26712796 |
Amal I Hassan1, Mona A M Ghoneim2, Manal G Mahmoud3, Mohsen M S Asker3, Saher S Mohamed3.
Abstract
Damage to normal tissues is a consequence of both therapeutic and accidental exposures to ionizing radiation. A water-soluble heteropolysaccharide called AXEPS, composed of glucose, galactose, rhamnose and glucouronic acid in a molar ratio of nearly 1.0:1.6:0.4:2.3, respectively, was isolated from culture medium of strain Alcaligenes xylosoxidans MSA3 by ethanol precipitation followed by freeze-drying. Chemical analysis, Fourier-transform infrared (FTIR) and chromatographic studies revealed that the molecular weight was 1.6 × 10(4) g mol(-1). This study was designed to investigate the radioprotective and biological effects of AXEPS in alleviating the toxicity of ionizing radiation in female albino rats. A total of 32 female albino rats were divided into four groups. In the control group, rats were administered vehicle by tube for four weeks. The second group was administered AXEPS (100 mg/kg) orally by gavage for four weeks. Animals in the third group were exposed to whole-body γ-rays (5 Gy) and remained for 2 weeks without treatment. The fourth group received AXEPS (100 mg/kg) orally by gavage for two weeks before being exposed to whole-body γ-rays (5 Gy), then 24 h post γ-rays, they received AXEPS (100 mg/kg) in a treatment continuing till the end of the experiment (15 days after the whole-body γ-irradiation). Oral administration of AXEPS (100 mg/kg) significantly reversed the oxidative stress effects of radiation, as evidenced by the decrease in DNA damage in the bone marrow. Assessment of apoptosis and cell proliferation markers revealed that caspase-3 significantly increased in the irradiated group. Moreover, a significant decrease in the hematological constituents of peripheral blood, the chemotactic index and CD8+ T cells were observed in animals in the irradiation-only group, whereas an increase in the lymphocyte index was observed in animals in that group. In contrast, AXEPS treatment prevented these alterations. From our results, we conclude that AXEPS is a potent antioxidant and treatment agent for protection from γ-rays.Entities:
Keywords: Alcaligenes xylosoxidans; chemical structure; oxidative stress; polysaccharide; γ rays
Mesh:
Substances:
Year: 2015 PMID: 26712796 PMCID: PMC4795946 DOI: 10.1093/jrr/rrv075
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Fig. 1.Phylogenetic neighbor-joining tree obtained from the 16S rDNA sequences of strain NRC-47 and members of related bacteria. Numbers at branch points are bootstrap values for parsimony-based analysis.
Fig. 2.Elution curve of AXEPS from Alcaligenes xylosoxidans MSA3 over DEAE-cellulose column. The absorbance at 490 nm was that of the resulting reactive solutions of polysaccharides, phenol and sulfuric acid.
Fig. 3.Molecular weight distributions of AXEPS production by Alcaligenes xylosoxidans MSA3.
Fig. 4.FT–IR spectrum of the AXEPS from Alcaligenes xylosoxidans MSA3 in the range 400–4000 cm−1.
Fig. 5.Scavenging effect of polysaccharide fraction AXEPS during DPPH test and measured by changes in absorbance at 517 nm.
Effect of AXEPS on the hematological constituents in irradiated rats
| Groups | Normal (GI) | AXEPS (GII) | Irradiated (GIII) | Treatment with AXEPS | |
|---|---|---|---|---|---|
| (GIV) | |||||
| Hb (g/dl) | 12.39 ± 0.32a | 13.41 ± 0.69a | 9.69 ± 0.41b | 12.45 ± 11.60a | 10.852* |
| PL (PLTC/C mm) | 588.50 ± 37.9a | 591.25 ± 31.54a | 394.50 ± 24.13b | 566.50 ± 36.88a | 7.310* |
| WBCs (cells × 103/mm) | 12.87 ± 0.12a | 12.58 ± 0.23a | 9.55 ± 0.63b | 11.82 ± 0.70a | 8.039* |
| RBCs (cells × 106/mm) | 6.35 ± 0.45a | 6.44 ± 0.30a | 4.82 ± 0.18b | 5.99 ± 0.51ab | 2.83† |
| PCV (%) | 39.79 ± 2.10a | 37.65 ± 1.19a | 27.10 ± 1.27b | 36.25 ± 1.93a | 7.578* |
Data expressed as mean ± SE. a,b and ab: Statistically significant from control or radiation group, respectively at P < 0.05 using one-way ANOVA followed by Tukey–Kramer as a post hoc test. *F value (P < 0.05); † P = 0.668 (P > 0.05).
Effect of AXEPS on CD8+ T, caspase-3, TNF-α, chemotactic index and LT in irradiated rats
| Groups | Normal (GI) | AXEPS (GII) | Irradiated (GIII) | Treatment with AXEPS | |
|---|---|---|---|---|---|
| (GIV) | |||||
| CD8+ T (%) | 22.84 ± 1.21a | 21.45 ± 0.93a | 13.99 ± 1.74b | 21.80 ± 1.66a | 6.76* |
| Caspase3 (ng/ml) | 3.44 ± 0.11b | 3.36 ± 0.15b | 5.66 ± 0.08a | 3.45 ± 0.28b | 16.699* |
| TNF-α (pg/ml) | 81.90 ± 6.26c | 78.09 ± 1.13c | 120.33 ± 2.64a | 98.19 ± 1.73b | 54.255* |
| Chemotactic-index | 1.60 ± 0.01b | 1.87 ± 0.03a | 1.31 ± 0.02c | 1.54 ± 0.04b | 43.56* |
| LT | 1.73 ± 0.10b | 1.92 ± 0.12ab | 2.44 ± 0.37a | 1.65 ± 0.14b | 3.02† |
Data expressed as mean ± SE. a, b, ab and c: statistically significant from control or radiation group, respectively at P < 0.05 using one-way ANOVA test followed by Tukey–Kramer test as a post hoc test. *F value (P < 0.05); † (P > 0.05).
Effect of AXEPS on genomic DNA in irradiated rats
| Groups | Normal (GI) | AXEPS (GII) | Irradiated (GIII) | Treatment with AXEPS | |
|---|---|---|---|---|---|
| (GIV) | |||||
| Tail DNA (%) | 1.57 ± 0.04c | 2.65 ± 0.27b | 3.39 ± 0.42a | 3.15 ± 0.08ab | 9.148* |
| Untailed (%) | 95.50 ± 0.88a | 95.33 ± 0.9a | 81.33 ± 0.67c | 86.33 ± 0.88b | 71.133* |
| Tail length (µm) | 1.78 ± 0.43c | 1.31 ± 0.14c | 4.92 ± 0.41a | 3.00 ± 0.25b | 27.594* |
| Tail moment | 2.78 ± 0.61c | 3.41 ± 0.21c | 16.33 ± 0.96b | 9.43 ± 0.57b | 101.39* |
Data expressed as mean ± SE. a, b, ab, and c: statistically significant from control or radiation group, respectively at P < 0.05 using one-way ANOVA test followed by Tukey–Kramer test as a post hoc test. *F value (P < 0.05).
Fig. 6.Effect of AXEPS on genomic DNA in irradiated rats: (A) control; (B) rats treated with AXEPS only; (C) irradiated rats; (D) irradiated rats treated with AXEPS 2 weeks before γ rays and continued till 15 days after γ rays.
Pharmacological study of acute toxicity (LD) testing
| Doses (mg/kg) | Result of first phase (mortality) |
|---|---|
| 10 | 0/3 |
| 100 | 0/3 |
| 1000 | 1/3 |
| Doses (mg/kg) | Result of second phase (mortality) |
| 1600 | 1/3 |
| 2900 | 2/3 |
| 5000 | 3/3 |